CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer-Reference-Cited by-同舟云学术

CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer

Published:2022-12-10 Issue: Volume: Page:
ISSN:1591-9528
Container-title:Clinical and Experimental Medicine
language:en
Short-container-title:Clin Exp Med

Author:

Li Ming,Li Shanglin,Zhao Ruocong,Lv Jiang,Zheng Diwei,Qin Le,Li Siyu,Wu Qiting,Long Youguo,Tang Zhaoyang,Tang Yan-Lai,Yang Lihua,Yao Yao,Luo Xuequn,Li Peng

Funder

Youth Talent Promotion Project of Guangzhou Association for Science and Technology

Guangdong Provincial Significant New Drugs Development

Science and Technology Program of Guangzhou, China

National Key Research and Development Plan

National Natural Science Foundation of China

Youth Innovation Promotion Association of the Chinese Academy of Sciences

Guangzhou Science and Technology Plan Project

Frontier Research Program of the Guangzhou Regenerative Medicine and Health Guangdong Laboratory

Science and Technology Planning Project of Guangdong Province, China

Open Project of the State Key Laboratory of Respiratory Disease

University Grants Committee/Research Grants Council of Hong Kong

Innovation and Technology Fund (ITF) from the Hong Kong SAR government

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10238-022-00967-1.pdf

Reference42 articles.

1. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–91.

2. Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. 2020;159(1):335–49.

3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

5. Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med. 2013;368(16):1509–18.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses;Cell Communication and Signaling;2024-01-19